IDT specialises in the development, scale-up and production of active pharmaceutical ingredients to international standards of Good Manufacturing Practice. IDT has over 10 years experience in the handling of :-
  • Cytotoxic Active Pharmaceutical Ingredients (API's)
  • High Potency API's
  • Hormones
  • Toxic Reagents

IDT currently manufacture Active Pharmaceutical Ingredients (API's) for world-wide clients in its FDA inspected containment facilities located in Melbourne Australia.

Pharmaceutical companies are increasingly recognising the benefits of outsourcing research and development to assist with their development and clinical programs.

IDT also specialises in the entire post-discovery pharmaceutical life cycle. Our expertise in the development of new chemical entities from laboratory-scale to full-scale production, combined with our ability to conduct phase I-IV clinical trials, uniquely positions IDT to assist companies at many stages from synthesis to market level production.

Our services to the pharmaceutical industry can be divided into four main segments on the development timeline:

IDT provides a powerful integrated package for pharmaceutical product development, from production of APIs through to manufacture and packaging of clinical trial materials and managing of clinical trials under international Good Clinical Practice requirements.

Don’t let distance become a barrier to efficient, high quality and competitive drug development. Contract IDT as your outsourcing pharmaceutical partner today.

For a no obligation, free quote contact IDT:

E-mail : webmaster@idtaus.com.au